The University of Southampton

Science: Fixing Plastic Pollution or Making it Worse?

Realising the contribution of science to plastic pollution

David Attenborough’s poignant message about plastic pollution, from Blue Planet II in 2017. Available at https://www.youtube.com/watch?v=IW3jEIYBFzg

I have always been aware of the common sources of single-use plastics and how these are being reduced. One of the most influential discussions around plastic pollution in recent years was David Attenborough’s message in Blue Planet II in 2017. Since then, many beneficial changes to our day-to-day life have been implemented, including the ban on plastic straws in 20211 and the introduction of the carrier bag charge, also in 20212. Part of my keen interest in science is due to its ability to improve the sustainability of various sectors. However, a lot of the lecture content on this module has focused on the wastefulness of things I had previously not considered, such as prosthetic sockets, or wheelchairs not appropriate for their use. When I first entered a clean chemistry laboratory as part of my independent research project, I was shocked to see this wasteful side of science first-hand. The pictures below are ones I took. From left to right:

  • A tub filling up with single-use pipette tips, which will not be recycled (“please empty when full to general waste bin”).
  • A bin full of discarded nitrile gloves, some used for as little as 5 minutes with no contaminating substances on. This is 1 of about 5 of these bins in this laboratory alone. They fill up daily and are “non-recyclable waste”. This one particularly shocked me.
  • A rack of single-use sample vials. These vials are being used for one stage of an experiment after which they’ll be thrown away.
The pictures I took in the clean chemistry laboratory at NOCS, highlighting the extent of the plastic wastage.

This is just the tip of the iceberg: in 2014, it was estimated that research laboratories generated 5.5 million tonnes of plastic waste globally1.

Digging deeper

Seeing as I thought the plastic waste from one laboratory was excessive, I was interested in the scale of plastic waste from labs both in the UK and globally, and what was being done, if anything, to mitigate the issue. I attended a talk on plastic pollution by Professor Ian Williams, a Professor of Applied Environmental Science, where the issue of science’s contribution to plastic pollution was raised. Professor Williams acknowledged the huge issue of single-use plastic in science, particularly in hospitals where everything is single-use to maintain a sterile environment. However, he also said that there is “intent [to reduce the problem], but we are not quite there yet”. An example he raised was the LEAF project, which I hadn’t heard of and so decided to research further.

The LEAF sustainability project3.

LEAF is a new approach to laboratory sustainability, developed by Sustainable UCL. It contains advice for laboratories on how to save plastics and other resources. Laboratories are awarded either a Bronze, Silver or Gold level, depending on their level of sustainability3. Some labs in Southampton have a Bronze Award, but in my opinion, we could do more.

Moving forwards

Luckily, some universities have implemented schemes to avoid wasting as much plastic. When researching more about single-use nitrile gloves, I found out that the University of Edinburgh has a glove recycling scheme in the School of Chemistry that recycled over a million plastic gloves in 20191. Additionally, in 2018 the University of Leeds pledged to remove single-use plastic from the entire university, including its research laboratories, by 20231.

In the future, interdisciplinary modules are ever-more important in bringing people from different sectors together to critically analyse the world we live in, and discuss how we can improve it. This module has made me think more broadly about the drawbacks of science as well as the benefits, and the steps that can be taken to mitigate these drawbacks.

References

  1. Alves, J. et al., (2020). A case report: insight into reducing plastic waste in a microbiology laboratory. In: Access Microbiology (3/3). London: Microbiology Society.
  2. UK Government, (2022). Carrier bag charges: retailers’ responsibilities. [online]. Available at https://www.gov.uk/guidance/carrier-bag-charges-retailers-responsibilities [accessed 21/03/23].
  3. Sustainability Exchange, (2023). LEAF – A New Approach to Achieving Laboratory Sustainability. [online]. Available at https://www.sustainabilityexchange.ac.uk/leaf_a_new_approach_to_achieving_laboratory_sus [accessed 23/03/23].

Are liposomes the future of cancer treatment?

According to the NHS, 1 in 2 people develop cancer at some point in their life. Unfortunately, I was able to see the devastating effects that chemotherapy and radiotherapy can have on a patient through my grandmother. Studying biomedical sciences incited me to research new technologies that are being developed in order to aid cancer treatments and I came across the use of nanoparticles but more specifically liposomes.

What are liposomes?

Liposomes are organic nanoparticles that are being widely studied by scientists, consisting of a bilayer of phospholipids that come together to form vesicles that are non-toxic, non-immunogenic and biodegradable. They have the ability to deliver active pharmaceutical ingredients by either encapsulating hydrophilic molecules inside the vesicle or by entrapping hydrophobic molecules in the lipid bilayer.

Not only do they have the ability to carry drugs but also can improve the delivery of antigens and other molecules to our immune cells, helping them destroy the cancer cells!

What characteristics make liposomes a good drug delivery system?

  1. Liposomes can deliver both hydrophilic and hydrophobic drugs, meaning that a large range of drugs can be delivered using them.
  2. They provide a protective layer around the drug which prevents degradation of the drug by the body and reduces the toxicity as the drug is not infecting the healthy cells in our body.
  3. The targeting of liposomes to cancer cells also increases the efficacy of the drug.
  4. Liposomes are biocompatible and biodegradable because they are made up of the same material as the membrane of cells, which minimises the risk of further side effects in our body.

So… what is the downside?

Up to this point, the use of liposomes sound like an amazing tool to be used in cancer research. However, scaling up the production of these liposomes makes it much more expensive than simply delivering chemotherapy to patients which could mean that people with less resources will not be able to pay for the treatments. Liposomes have a short shelf-life which means that if the drug has not reached the cancerous cells before this, the drugs will be delivered to healthy cells instead. Furthermore, they are susceptible to aggregations that can change their size and shape and possibly leading to unwanted drug release. The use of liposomes can also lead to hypersensitive or inflammation reactions, putting patients at risk.

Are these disadvantages much worse than the side effects caused by months of hospital visits in order to get chemotherapy and radiation?

Personal opinion

I believe that the idea of liposomes to be used for cancer treatment is one of the many amazing ideas that scientists are coming up with in order to improve the life of many. The use of liposomes in the field on oncology could have the potential to efficiently deliver drugs that are able to kill cancer cells and there are ongoing clinical trials for using them in certain types of cancer such as prostate cancer. However, I think that further improvements have to be made in order for this to be a safe and efficient drug delivery method we can use on humans. Scientists need to keep investigating the use of liposomes and also other nanoparticles in order to come up with a better solution to cancer than chemotherapy and radiation.

Ted talk from Joy Wolfram who talks about her research of nanoparticles in the field of oncology.

For further scientific readings on liposomes:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879473/#:~:text=Compared%20with%20traditional%20drug%20delivery,and%20lower%20toxic%20side%20effects.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017847/

‌

Medical Cadavers Throughout History

As someone who is very interested in biological fiction, I am currently reading ‘The Body’ by Bill Bryson. I came to the chapter, ‘In the Dissecting Room: The Skeleton,’ and was intrigued to hear that medical cadavers have been the topic of various controversies throughout history. Soon after reading this, I also attended the ethics and law lecture, which led me to delve deeper into the issues and history of acquiring medical cadavers for teaching.

‘The body’ by Bill Bryson. The book that sparked my curiosity of medical cadavers. https://www.waterstones.com/book/the-body/bill-bryson/9780552779906

Where did medical cadavers previously come from?

Public opinion of dissection around the 18th and 19th century, even for the benefit of science, was seen as sickening and disrespectful. Fitting with the questionable ethos of the time, only hung criminals were seen to warrant this brutal fate. I was appalled to discover that this was justified by judges who believed murderers deserved further prosecution after their execution, so offered their bodies up for dissection without choice.

Why did this need to change?

Still, there never seemed to be enough cadavers to distribute between medical schools. Bryson mentions in his book that in 1831, London had 900 medical students with only 11 cadavers. This ultimately led doctors to turn to grave robbing. These hellish actions were not a punishable offence at the time, which only encouraged them to continue. I was shocked to hear this, but it made me realise that legal enforcement was the only way forward to put a stop to the clearly desperate thievery. My research led me to find that the Anatomy Act of 1832 was enforced because grave robbing had gotten too out of hand. This allowed medical institutions to also take ownership of the bodies of unclaimed poor persons.

Cadavers are dead human bodies that are preserved and used by medical schools to aid the teaching of anatomy to students. https://en.wikipedia.org/wiki/Cadaver

While this seemed to fix the shortage and improve standards of anatomy textbooks, I found it shocking to believe that the financial status of a person upon their death should determine the fate of their body. Can the sacrifice of convicts and the poor be justified for the greater good of science? Rather than discarding abandoned bodies, should they be put to better use? I can see balance in this argument, but it is hard to believe doctors had free license to dissect unclaimed bodies. This opinion was shared by many.

“They tell us it was necessary for science. Science? Why, who is science for? Not for poor people. Then if it is necessary for science, let them have the bodies of the rich, for whose benefit science is cultivated.” – William Cobbett (1763-1835, advocate for English poor and working-class)

Where do medical cadavers come from now?

Under the Human Tissue Act 2004, written and witnessed consent for anatomical examination is required prior to death, it cannot be made by anyone else after a person has died. In the UK, It is illegal to buy and sell human remains, therefore modern medical schools rely entirely on donations of those willing to give their bodies for science. I was even pleasantly surprised to hear that some schools are positively overwhelmed by donations that they must turn away excess offerings.

A current perspective:

I was intrigued to see what current medical students thought about cadavers and the regulations implemented by Southampton University. I consequently conducted a short interview with a student which I found very insightful, as shown below.

Video of the short interview I conducted with a current medical student at the University of Southampton.

A real-life nightmare:

News article describing the incident of a Nigerian medical student that attended an anatomy lesson which used the dead body of his former friend that had been shot, killed and unclaimed. https://www.bbc.co.uk/news/world-africa-57748122

Unfortunately, I was devastated to find that some countries still use unclaimed bodies for teaching. I found a truly awful news article where a student from the University of Calabar in Nigeria was traumatized by an anatomy class that used the dead body of his friend. I discovered that 90% of Nigerian medical cadavers are criminals killed in shootings. Whilst this story truly horrified me, it shows that there is still a global shortage of legitimate cadavers .

I believe there should be tighter universal regulations that limit the distribution of unclaimed bodies for science, but similarly increase international positive awareness to encourage more people to donate their bodies. This may be the only solution to permanently fix shortages without overstepping ethical practice.

Ethics of Reducing Prison Sentences in Exchange for Organ Donation 

Prisoners are those who owe a debt to society, they are made to pay for this by giving their time and freedom in proportion to the crime. Although an effective deterrent against breaking the law, it lacks any active use to society – no substantial payment is being collected. This could change with two democratic representatives offering reduced sentences of “not less than 60 and not more than 365-day reduction in the length of their committed sentence” for organ donations. This ethical section of the module is one which engaged me the most as if forced me to consider viewpoints and problems that I hadn’t been exposed to before in the entire course which was very stimulating and hence the motivation for writing about this specific topic. 

This proposal ultimately offers prisoners an alternate method of paying their societal debt, one that benefits those in most need of it. Of course, there are many denouncers who have this proposal in their crosshairs, shooting ethical and legal arguments at it. In this blog, I will present these arguments and question or dismantle their validity primarily through a utilitarian mode of thinking. One of the main gripes with this potential bill is that it gives prisoners an ‘easy way out’ of their punishment. Perpetuators of this line of reasoning will be displeased to learn of sentence credits and parole which can be granted on basis subjective as good behaviour. If reading books and attending vocational seminars can reduce a sentence, why should organ donation, an act with far greater positive effects be treated any differently? 

 Another point of contention that was brought up during the lecture is the intentions of the prisoners, that unlike positive programs prison programs done for their improvement, organ donation is simply a shortcut. This argument has the potential of being very true but is simultaneously irrelevant. To illustrate my point here is a statistic to do so: According to the World Health Organization (WHO), approximately 17 people die each day in the United States alone while waiting for a transplant, which amounts to over 6,000 deaths per year. Similarly, in the European Union, over 10,000 people die each year while waiting for a transplant. I believe any meaningful reduction in this number is an overall benefit that outweighs any nefarious intentions prisoners may have to ‘circumvent’ punishment. 

When discussing this topic, it was hard not to imagine a loved one in a position where they needed an organ from a prisoner that would receive a reduced sentence, to me it seemed an obvious choice. Personalising the proposal probably skewed my objectivity and made the personal benefits outshine any real societal negatives that became too hard to see in comparison, but when dealing with ethics there is no objectivity and anecdotes replace averages, ironic considering my utilitarian thinking cap.  

Although there are advantages to this proposal highlighted in this blog, there are real concerns that arise like whether it is unfair to take advantage of the situation prisoners are in for donations or for prisoners’ health post-operation. It is these types of questions that engage me so much with this aspect of the course and allow me to appreciate the complexity, grey-ness and probably the futileness of trying to marry science to ethics whilst still making it a worthwhile venture. 

Science to Philosophy. Senses and Reality

I think, I am.

These famous words were written by Rene Descartes in his book Meditations in 1641. It deals with the philosophical theory of knowledge or as known as epistemology. The reason I am writing the blog on this topic is derived from the lecture in week 6. During this, the lecturer mentioned sensation and haptics in prostheses that bring another level of sensory input for the disabled. This topic echoed my previous reading on Descartes. In the book Meditations, Descartes advocates the separation between the mind and the senses. Where senses are gathered from experiences, the mind holds some fundamental knowledge. For example, Descartes gave the example of a dream argument, that the senses in a dream can deceive a person, such as the smell and the touch. But fundamental knowledge such as colour, and the three-dimensional environment are the same as reality. While the senses can be wrong, and the mind is fundamental, as a result, the separation enables one to seek the fundamental truths, as Descartes argues. However, Descartes is also a mathematician. And the fundamental truths in Descartes’ view are factors that form our reality, such as physics, and 1+1=2. But what about the senses? Our own way of perceiving reality?


For matters such as a person predicting when the bus will arrive, or the action of a person if one says certain phrases to them, the prediction can usually be correct, only if they have gathered enough knowledge through senses in the past. This type of knowledge can be fitted into Bourdieu’s theory of practice, where some of the predictions are formed by habitus, in another word, a societal structure that determines how we think and act.


But what about instincts? A newborn baby will instinctively seek nutrients, we breathe with our lungs without learning it from schools, and we retract our hand muscles when we touch something hot. These actions are not determined by habitus but by stimuli. Lorenz’s research on animal instincts (ethology) with ducklings points toward that the hatchlings are born with learning programmes, which only need to be activated by stimuli. The ducklings were born to be attracted to certain stimuli that resemble the features of a mother hen, which is similar to human infants learning to recognize faces. Humans have fight-or-flight instincts that trigger certain parts of the brain when faced with dangerous situations. We also eat, drink, and rest based on body chemistry.

Reflection

Based on scientific evidence, the habitus of society, as mentioned, guides one’s behaviour. Yet the habitus itself is created through a social pattern. And it could be argued that social patterns are based on biological responses. One could, as I did as well, fall into the trap of a nihilistic view on this matter, that society is nothing but a complex exchange of chemistry responses that guides what we perceive as the “reality”. However, “I think, I am”, I refuse to be defined by a set of chemistry responses, but through my senses, and what I experienced throughout time.


From this mode of thinking, strong moral support for medical advancement can be derived. Imagine the reality perceived by someone who suffers from nerve damage that affects any of the five senses since birth. The reality perceived by them will be totally different. Without medical advancement for prostheses and other surgical treatments, living in a reality without realising the reality is false due to uncontrollable factors is a really cruel thing to think about. Like Descartes’ theoretical example of a deceptive god that intentionally created reality to always be false. It is a great evil if this was to be true. As such, some medical advancements can really be something to be awe of.

The Lessons of the Asilomar Conference: Self-Regulation in Science and the Importance of Public Transparency

As a biomedical sciences student, what initially drew me to this module was my interest in stem cells and genetic engineering. I am currently reading The Genetic Age: Our Perilous Quest to Edit Life by Matthew Cobb, which chronicles the history of gene editing, from its advent in the 1960’s to our current day. In it, he recounts the 1975 Asilomar Conference on Recombinant DNA, and its lasting impact on how scientists maintain their ethical responsibility of public safety.

From left to right: biologists Maxine Singer, Norton Zinder, Sydney Brenner, and Paul Berg discuss the safety of experiments involving recombinant DNA in the Asilomar Conference Centre, California, 1975.

SV40 and Asilomar

In 1974, Paul Berg was attempting to use tumour-causing simian virus 40 (SV40) to introduce the E. coli lac gene into mammalian cells. He also successfully introduced SV40 into E. coli, which became one of the first successful recombinant DNA experiments. However, this led to concerns from other scientists that the bacteria containing SV40 could escape his lab and cause cancer in infected people. Berg agreed to place a temporary moratorium on all recombinant DNA experiments, leading to a lot of panic in the public, as people rightfully wanted to know just how dangerous these experiments were.

Paul Berg was born on June 30, 1926. He was a professor of biochemistry at Stanford University from 1959 to 2000 and won the Nobel Prize in Chemistry in 1980 for his contributions to the understanding of the biochemistry of nucleic acid and his pioneering work with recombinant DNA. He passed away on February 15, 2023, at the age of 96.

In 1975, Berg and around 100 other scientists in his field gathered at Asilomar Conference Centre, California to draw up safety guidelines for recombinant DNA experiments, with reporters present. Over several days, they discussed bio-safety precautions and which experiments should and shouldn’t be taken. Some took a very utilitarian approach, arguing that a few people hypothetically getting infected by an escaping virus was outweighed by the potential benefits of recombinant DNA technology, and that any guidelines were impinging on their academic freedom as scientists. Others argued that even one person hypothetically getting cancer was too much of a risk. Eventually, the participants were able to agree on safety protocol and containment strategies for recombinant DNA experiments and even prohibited some that were considered too dangerous.

The Lessons of Asilomar

In 2008, Berg published an opinion piece in Nature Magazine reflecting on Asilomar and posing the rhetorical question of whether another similar conference would resolve the current controversies in science at the time: “foetal tissue, embryonic stem-cell research, somatic and germ-line gene therapy and the genetic modification of food crops”.

While Asilomar’s participants didn’t discuss the ethical nor social aspects of genetic engineering and only focused on the health risks of the specific recombinant DNA experiments, it was the first example of wide-scale self-regulation within the scientific community. It created an expectation for the same standard of social responsibility to be applied to all future forms of genetic engineering and its associated technologies.

A re-evaluation of self-regulation

In his Asilomar opinion piece, Berg brings up an important and worrying point: most scientists in recombinant DNA research at the time worked in public institutions whereas scientists today often work for private biotechnology companies. They are at the behest of their employers, forced to place the financial interests of the companies before the health and safety of the public.

In his book, Cobb points out that public decision-making in genetic engineering has been limited so far. At Asilomar, policy was only made between scientists with some input from lawyers. There were reporters present but only for transparency’s sake; public trust was gained, but they weren’t involved in the process itself. He argues that the potential impact of today’s gene editing technologies means that “public involvement in decision-making, on the basis of open experimental data rather than secrecy and suspicion, needs to become widespread and routine” and “it is only because of public disquiet that has prompted the introduction of regulatory control that genetic engineering thus far has been safely deployed”.

My thoughts

I agree with Cobb that there must be an open and stronger line of communication between scientists and the public. Genetic engineering is a constantly evolving frontier of biomedical science, with new frontiers being discovered constantly. It is far too easy to be swept up in the excitement of it all and tumble down the rabbit hole, performing unnecessary experiments in the name of progress and notoriety, like in the case of He Jiankui’s embryo-edited twins. There are numerous ethical implications surrounding genetic engineering; it toes the line between life-saving somatic therapies and flirtations with – if taken too far – eugenics.

In 2018, Chinese biophysics researcher He Jiankui controversially announced he had used CRISPR-Cas9 to edit the genomes of the embryos of twin baby girls to be resistant to HIV infection.

Science should be for the benefit of many, not few. All people deserve to have access to important and life-saving technologies and furthermore, should have knowledge of and a say in how those technologies are regulated and applied. In his own opinion piece about Asilomar, pioneering microbiologist and conference participant Stanley Falkow wrote in 2012: “The (very privileged) social contract by which science is sustained depends on the public continuing to understand why this work is beneficial and worthwhile.” And more than a decade later, his words ring truer than ever.

References

Berg, P., 2008. Asilomar 1975: DNA modification secured. Nature, 455(7211), pp.290-291.

Cobb, M. (2022) The Genetic Age: Our Perilous Quest to Edit Life. London: Profile Books.

Falkow, S., 2012. The lessons of Asilomar and the H5N1 “affair”. MBio, 3(5), pp.e00354-12.

The anencephalic new-born organ donor

Amidst an ethical debate regarding organ donation in an ethics and law workshop, the complexity of the discussion inspired me to delve further into the moral and legal implications of organ donation. While it is true that organ donation is a lifesaving procedure, it is interesting that when it comes to infants with life-threatening illnesses, it’s not so easy.

Case study

For example, Mrs Z, a young, overdue, pregnant woman underwent an ultrasound examination and was told that her baby was anencephalicA condition where no brain is present except for portions of the brain stem and there is a high likelihood the baby will be born underdeveloped and stillborn. Heart and kidney transplants could be possible.

In light of this, the mother decided to volunteer her baby as an organ donor. Despite her wishes, the moral debate began as physicians became uncertain on what steps to take. If they accepted the mother’s wish to donate organs, is it their duty to try and resuscitate the baby if it was still born? Should they accept her wishes at all? When should or could the baby’s death be pronounced?

Moral Panic

Mrs Z’s case is a controversial debate, predominantly due to the moral and legal obstacles to taking organs from a pre-diagnosed anencephalic new-born.

To start, following the mother’s requests would be a way to alleviate the growing shortage of vital organs for organ recipients in need. Organ size restrictions mean that strategies to increase donation rates may not be of much use. However, there have been cases where ‘miracle babies’ have lived long after expected. How do we determine who takes priority?

In addition, under current law, organs can be taken from patients who are ‘brain-stem dead’. Despite brain absence, an anencephalic infant does not meet this criterion as they retain a functional brain stem that can maintain vital functions. So, by law, the mother’s desire to donate may not be permitted. The baby should be treated as they would ordinarily be treated, regardless of determined death. Would we normally resuscitate a still-born infant? Prolong suffering? Yet, if these organs have the ability to save the lives of dying infants, I believe that the organs should be donated, provided the baby does not suffer.

Finally, in actuality, there is no reason why the parents shouldn’t be able to donate the organs of their baby to suitable recipients, provided it follows the death of their child. But… the glorification following the words ‘organ donation’ makes me wonder if the parents were informed on alternative approaches for recipients, such as stem cells or Norwood staged surgery. Were they aware that the absence of a major part of the brain doesn’t imply instant brain death? Is this pure utilitarianism? I believe it should be standard that families who request organ donation from their anencephalic baby should be given concise information and educational material provided on the practice and its implications.

Final thoughts

In my opinion, if there is a way to donate Mrs Z’s baby’s organs without drastically intervening standard treatment, organ donation should proceed. However, the answer differs if a significant alteration occurs. Going above and beyond to prolong gestation on a distressed infant in order to ‘mature’ organs for donation requires moral reservation.

Nevertheless, recent research has diminished the idea of anencephalic new borns as organ donors, with the exception of theoretical debate and case studies. The American Academy of Paediatrics (1992) concluded that organ donation from anencephalic infants should not be undertaken due to the serious difficulties surrounding the establishment of brain death and limited success rates.  

Miracle Baby Born Without Most of His Brain Defying Odds – https://youtu.be/wu47BpI4ld8

Diabetes- The Complications Of A Cure

Context

Diabetes type 1 is a chronic and exasperating condition. Although I do not experience it myself, I have witnessed the tedious effect it has on lives. Management of diabetes is a growing field where further development of instruments such as the libre are becoming increasingly user friendly and accurate.

This image displays the libre on the bicep of this user. It is a cannula device which stores glucose readings every 15 minutes. A trend graph and further details can be accessed through the app LibreLinkUp (https://www.healthline.com/diabetesmine/abbott-freestyle-libre-review).

Witnessing someone close to me have to use the Libre and insulin pump daily, I saw how inconvenient the condition is; if there is a problem with the users ratios, their whole persona can change or their health turns to worse. I empathize with those who have to deal with diabetes day to day and those who may not find it as easy to manage because of other conditions. This module has nurtured my interest from lecture 2 as I have thought about the possibilities to either develop monitoring, or engineering of the beta cells themselves. The workshop station with Kirsten O’Brien and the tissue engineering lecture displayed to me how stem cells can be grown. These sprouted thoughts into allergenic cell transplantation and the complications of accessibility to pancreatic stem cells.

Cell staining of the Islets of Langerhans using immunohistochemistry, the beta cells which produce insulin are illustrated in green and the alpoha cells stained red produce glucagon. Nucleus are in blue (https://blogs.bcm.edu/2019/10/01/from-the-labs-image-of-the-month-islet-of-langerhans/).

Current Research

There’s research into treating beta cells or replacing them using stem cells. Clinical islet transplantation has been explored – however there are issues with supply and demand, or quality of life for the patient, as they would have to use immuno-suppressants avoiding immune mediated graft loss/ potential organ failure. Materials such as scaffolding could be used in an islet transplant to protect from mechanical stress and aid the remodelling of the tissue.

However a controversy lies with, where do these replacement beta cells originate?

Complications Arise

Embryonic stem cells are the ideal candidate for use in this research, as there is higher replicability with differentiation and they have a success rate of up to 80%. The pleuropotency of ESC (embryonic stem cells) is the heaviest advantage as it allows the potential to replace faulty tissue. However, using these will result in the death of an embryo.

This raises ethical debates -when is an embryo considered conscious? Researchers can use aborted embryos with informed consent from the mother, although my mind goes to what happens to failed IVF attempts, hoping that the embryos would go towards research rather than discarded.

1.7 Million Human Embryos Created for IVF Thrown Away

Quote from the telegraph- This is outdated and not from a reliable source, however is still a considerable figure to give some thought about with bias.

Another complication to consider, is how to treat those who would refuse stem cell researched cures- because of religious views. In my opinion this should be heavily considered, as nobody should receive less medical care because of their faith, even if they refuse to accept the treatment. Would developing the Libre and pumps be an acceptable quality of life, or must induced pluripotent stem cells become further developed to avoiding these dilemmas?

From an economic standpoint, research into diabetes treatment would be a huge investment for the NHS. Evidence has shown that the NHS spends around £10 billion a year on diabetes. Shockingly, this equates to £25,000 a minute. Therefore not only would the quality of life be improved with research into a cure, but the government would also benefit, which I believe could be a huge motivator to diabetic research; quite sadist unfortunately. This makes me think further into whether diabetics would receive the research if they did not cost the NHS so much.

Summary Of My Thoughts

Reflecting on the impact this module has had on my thoughts about this, there are many options of research out there that could potentially cure type 1 diabetes, however the root of these treatments derive from a highly controversial source. From a holistic approach, using embryos would save many more lives than it would cost to research; however alternatives should receive more attention not just for ethical reasons but religious perspectives which can be overlooked in research and need more representation.

Further Information

https://www.science.org/doi/10.1126/science.abh1657– Scientific Article regarding topics discussed with higher scientific details.

Alternative Current Research

This video from The neutronium alchemist talks about research into a new molecule for treating diabetes which would avoid the ethical implications from stem cell research

References

  1. Chung, H., Lu, Y., Oh, J., Wu, Z., & Im, K. (2021). Engineered bacterial outer membrane vesicles as a versatile platform for biosensing. Science, 373(6554), 148-153. https://doi.org/10.1126/science.abh1657

2. NHS England. (2022, March 16). NHS prevention programme cuts chances of type 2 diabetes for thousands. Retrieved from https://www.england.nhs.uk/2022/03/nhs-prevention-programme-cuts-chances-of-type-2-diabetes-for-thousands/#:~:text=Evidence%20has%20shown%20that%20the,effective%20in%20the%20long%2Dterm.

3. Priority You MD. (2021, May 7). What Is the Success Rate of Stem Cell Therapy? Retrieved from https://priorityyoumd.com/what-is-the-success-rate-of-stem-cell-therapy/#:~:text=The%20popularity%20of%20stem%20cell,biological%20component%20called%20stem%20cells

Alzheimer’s Disease Treatment: US-Targeted Microbubble Drug Delivery

The stem cell and regenerative medicine workshop introduced me to a new advanced tissue engineering discipline: the use of microbubbles. I was fascinated to learn that many disorders are incurable due to drug delivery transport implications and that the development of microbubbles has the potential to solve many of these difficulties.

Microbubbles (MB) are non-toxic and biocompatible technological structures that interact dynamically with organs at the cellular level. They have a size of 0.1- 10 Âľm and can be destroyed by ultrasonic radiation (US). The US can be targeted to specific locations, improving selective therapy. Tissue engineering with biomaterials is an innovative and promising technique for increasing human life expectancy, and scientists are interested in integrating MBs with scaffold architecture.

A simple animation I created to explain the process of the US-targeted microbubble

Alzheimer’s disease (AD) is the most common cause of dementia. It affects around 50 million individuals globally, and its prevalence is expected to double by 2050. There are currently no treatments to cure Alzheimer’s disease, although the FDA has approved drugs to treat symptoms. E.B White, the author of my favourite childhood novel Charlotte’s Web, is a notable person who sadly died of Alzheimer’s disease. He has suffered by losing his freedom and forgetting his accomplishments.

Memory loss, reduced cognitive function, and behavioural instability are hallmarks of AD

Alzheimer’s disease is characterised by the production of Aβ senile plaques and the aggregation of tau-mediated neurofibrillary tangles. According to recent findings, eliminating amyloid β oligomers and plaques using monoclonal antibodies may stop progression. However, a challenge is the efficient delivery of therapeutic drugs across the Blood Brain Barrier (BBB) for the treatment of central nervous system (CNS) diseases. The BBB is a thin membrane formed by endothelial cells that removes 98% of small-molecule medications and 99.9% of large-molecule therapies for brain diseases, causing drug transport-related issues. The BBB presents a significant impediment to the delivery of medicines to the brain. Yet, the US-targeted microbubble destruction can promote the entry of therapeutic molecules into specific CNS regions, enhancing gene-carrier absorption in damaged brain areas while preventing the loss of normal cells.

Click on the image to watch a video explanation of the Morris water maze test

Zhu et al., (2022) investigated the efficacy of US-targeted microbubble destruction (UTMD) in the dual delivery of beta-amyloid (Aβ) antibodies carried by MBs and neural stem cell (NCS) of AD. They used 27 transgenic mice (Tg) and 33 wild-type mice, who were allocated into two groups: control and MB with AB and/or NSCs. The Morris water maze test was used to investigate cognitive and memory processes. As we learned in class, tissue engineering research employs knockout mice, which are a type of Tg. These are genetically engineered mice that receive foreign DNA. The difference between knockout mice and Tg is that the latter has a foreign gene introduced into their gene, e.g., AD. They discovered that the BB opened in Tg mice given a combination of NCS and Aβ antibody UTMD group. Their memory performance and spatial learning improved, and they discovered a reduction in Aβ plaques in the hippocampus and cortex.

(540) Focused ultrasound and microbubbles to overcome the blood-brain barrier for drug delivery – YouTube
A detailed video of how microbubbles work in the brain

In conclusion, the use of MB could open a  plethora of solutions to incurable diseases such as Alzheimer’s. However, further research needs to confirm its efficiency. For example, the US successfully destroyed MB, but what debriefs particles? Could it raise any side effects? Furthermore, given that dementia primarily affects the elderly, some individuals may underestimate the importance of discovering a cure for AD. E.B. White did pass away from old age. Throughout my research, I came across the Alzheimer’s Society website, which collects real-life accounts of dementia patients. I’ve noticed that diagnosis is made to one but it affects the entire family. E.B. White’s son would read him his very popular books, to then be asked who the author was. Alzheimer’s is an emotionally and physically draining disorder that affects members of a family, thus treatment is sought to lessen the pain of diagnosed patients.

Eugenics – how we’ve come full circle

When you hear the word eugenics, most people immediately think of the Nazis, but there are still a lot of modern-day ethical issues surrounding the ideas of eugenics. First, let us define eugenics:

‘the study of how to arrange reproduction within a human population to increase the occurrence of heritable characteristics regarded as desirable’.

Now using this definition, we can look at how it relates to what the Nazis did and while not the first-time ideas of eugenics were used, it is the most well-known. They used their ideas of eugenics to ‘euthanise’ those within the state who were deemed to be ‘incurably ill’. This included thousands of disabled people who were considered to be unproductive members of the state and after this followed the larger groups such as the Roma, Sinti, and Jews. Here eugenics were used to justify the death of millions as a way of ‘population control’ which is very clearly a hugely ethical issue. While most people are completely against the Nazi uses of ideas of eugenics, there are some who believe that eugenics could be utilised again today in order to help overpopulation.

I became interested in this topic after covering the historical elements in our ethics and law lecture, so decided to do some more research on the subject and how it affects the world today. During my research I came across the fact that in 2019,  a group of 11,000 scientists signed a statement urging population control in order to slow down the death of the earth due to climate change. This idea that we should control the population in order to sustain resources is not new. However, these ideas have been trialled in the past with poor results, for example China’s one child policy that was implemented to stop the exponential population growth of the country actually led to more of an increase rather than slow its growth. While these ideas of eugenics follow on from historical ones there is a new form that we have seen develop in more recent years, the idea of designer babies.

The concept of designer babies is where genetic testing is done on a child being created via IVF in order to determine whether they will have certain characteristics. The concept of designer babies is arguably the most ethically challenging as originally, this testing was done only to determine whether the child would be healthy, but it is now being used as a way for potential parents to determine whether the child will fit their expectations of that they want them to look like. I would argue that this is a new form of eugenics as it is allowing people to follow the idea of only creating children who have desired characteristics and as stated earlier, this is the definition of eugenics.

With these new forms of ideas of eugenics, it seems as though we have come full circle. From the Nazis using eugenics as their reasoning for murdering millions of innocent people, to modern day ideas of a way to protect our finite resources and then to creating IVF children with specific characteristics, eugenics seems to be an inescapable way of thinking. There is no way to justify these ideas as they put lives at risk. They fell under the radar as an ethical issue after WWII but with the concept of designer children and a need to protect our planet they are once again becoming an ethical issue within our society.